The Economics of Male Birth Control
Geege Schuman stashed this in XY
Summarize for me: Are the economics good?
Nowadays, male contraceptive research is being held back on the supply side, not the demand side. According to Lissner, there is comparatively little commercial incentive to develop a new contraception product at all.
First of all, the market isn’t big enough, by pharmaceutical and healthcare standards: $4 billion nationwide. Contraceptive products take a particularly long time to develop and test, which increases the risk of an investment. “$4 billion may sound like a lot,” says Gary Gamerman, a former consultant to Lissner’s foundation and vice president of Afaxys, Inc., “but when you divide it out among a lot of different products, and take the time and effort to develop and test a completely new product, or just an improvement, you could easily spend $20-$50 million. To launch it you’re going to spend another $30-40 million in marketing. And the whole thing will take 5 years at the very minimum.”
You're right, those economics stink. Look elsewhere for business ideas. :)